Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · IEX Real-Time Price · USD
1.180
+0.020 (1.72%)
Apr 23, 2024, 11:18 AM EDT - Market open

Hoth Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Selling, General & Admin
4.216.133.821.912.930.51
Research & Development
3.484.937.532.892.121.02
Other Operating Expenses
002.752.52.660.97
Operating Expenses
7.6911.0714.17.37.712.5
Operating Income
-7.69-11.07-14.1-7.3-7.71-2.5
Other Expense / Income
0.150.310.18-0.1-0.01-
Pretax Income
-7.85-11.37-14.28-7.2-7.7-2.5
Net Income
-7.85-11.37-14.28-7.2-7.7-2.5
Shares Outstanding (Basic)
311000
Shares Outstanding (Diluted)
311000
Shares Change
184.69%34.07%80.63%34.90%82.16%-
EPS (Basic)
-2.30-9.50-16.02-14.50-21.00-12.50
EPS (Diluted)
-2.30-9.50-16.02-14.50-21.00-12.50
Free Cash Flow
-8.45-9.3-12.09-6.13-4.95-2.1
Free Cash Flow Per Share
-2.48-7.76-13.54-12.40-13.49-10.45
EBITDA
-7.85-11.37-14.28-7.2-7.7-2.49
Depreciation & Amortization
000000
EBIT
-7.85-11.37-14.28-7.2-7.7-2.5
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).